Glossary

Scale-Up and Post-Approval Changes (SUPAC)

February 27, 2012

The FDA-recommended testing and filing actions to be taken by a pharmaceutical firm when it changes the manufacturing processes of a drug product that has already been approved via an NDA or ANDA.

blog comments powered by Disqus